Characteristics of ST11 KPC-2-producing carbapenem-resistant hypervirulent Klebsiella pneumoniae causing nosocomial infection in a Chinese hospital
- PMID: 35522153
- PMCID: PMC9169163
- DOI: 10.1002/jcla.24476
Characteristics of ST11 KPC-2-producing carbapenem-resistant hypervirulent Klebsiella pneumoniae causing nosocomial infection in a Chinese hospital
Abstract
Background: The purpose of our study is to analyze the microbiological and clinical characteristics of carbapenem-resistant hypervirulent Klebsiella pneumoniae (CR-hvKP) that causes nosocomial infection.
Methods: We collected the carbapenem-resistant K. pneumoniae (CRKP) strains that caused nosocomial infection in a hospital in China and collected the relevant clinical data. We characterized these strains for their antimicrobial and virulence-associated phenotype and genotype and analyzed the clonal relatedness. We screened hypervirulent strains and compared them with non-hypervirulent strains.
Results: We retrospectively analyzed 62 CRKP strains that caused nosocomial infection in a tertiary hospital within 1 year, of which 41 (41/62, 66.1%) CRKP were considered as CR-hvKP. All CR-hvKP strains were multi-drug resistance (MDR) and the vast majority of isolates (39/41, 95.1%) were ST11 KPC-2-producing strains. Two hypermucoviscous isolates and 4 capsular types were found in 41 CR-hvKP. Twenty-nine isolates (29/41, 70.7%) showed hypervirulence in Galleria mellonella infection model. PFGE showed that ST11-KL47 CR-hvKP and ST11-KL64 CR-hvKP exhibited a high degree of clonality, while non-hypervirulent strains were not significant. CR-hvKP had higher positive rates of blaKPC-2 and blaCTX-M-65 and higher levofloxacin resistance (p < 0.001, p = 0.005 and p = 0.046, respectively) when compared to the non-hypervirulent strains. There was no significant difference between the two groups in terms of in-hospital mortality (7/41, 17.1% vs 5/21, 23.8%, p = 0.743).
Conclusion: Our research finds that ST11 KPC-2-producing CR-hvKP is the main type of CRKP that caused nosocomial infection, and clonal spread has occurred. We provide more information about CR-hvKP in health care.
Keywords: Klebsiella pneumoniae; carbapenem resistance; hypervirulence; nosocomial infection.
© 2022 The Authors. Journal of Clinical Laboratory Analysis published by Wiley Periodicals LLC.
Conflict of interest statement
All authors‐none to declare.
Figures


Similar articles
-
Epidemiological, phenotypic and genotypic characteristics difference of hypervirulent and carbapenem-resistant Klebsiella pneumoniae with different capsular serotypes.J Microbiol Immunol Infect. 2025 Aug;58(4):444-454. doi: 10.1016/j.jmii.2025.02.010. Epub 2025 Feb 28. J Microbiol Immunol Infect. 2025. PMID: 40055131
-
Emergence of hypervirulent and carbapenem-resistant Klebsiella pneumoniae from 2014 - 2021 in Central and Eastern China: a molecular, biological, and epidemiological study.BMC Microbiol. 2024 Nov 11;24(1):465. doi: 10.1186/s12866-024-03614-9. BMC Microbiol. 2024. PMID: 39528921 Free PMC article.
-
Characterization difference of typical KL1, KL2 and ST11-KL64 hypervirulent and carbapenem-resistant Klebsiella pneumoniae.Drug Resist Updat. 2023 Mar;67:100918. doi: 10.1016/j.drup.2023.100918. Epub 2023 Jan 3. Drug Resist Updat. 2023. PMID: 36610180
-
"Superbugs" with hypervirulence and carbapenem resistance in Klebsiella pneumoniae: the rise of such emerging nosocomial pathogens in China.Sci Bull (Beijing). 2023 Nov 15;68(21):2658-2670. doi: 10.1016/j.scib.2023.09.040. Epub 2023 Sep 29. Sci Bull (Beijing). 2023. PMID: 37821268 Review.
-
A global perspective on the convergence of hypervirulence and carbapenem resistance in Klebsiella pneumoniae.J Glob Antimicrob Resist. 2021 Jun;25:26-34. doi: 10.1016/j.jgar.2021.02.020. Epub 2021 Mar 2. J Glob Antimicrob Resist. 2021. PMID: 33667703 Review.
Cited by
-
Characterization of ST11 and ST15 Carbapenem-Resistant Hypervirulent Klebsiella pneumoniae from Patients with Ventilator-Associated Pneumonia.Infect Drug Resist. 2023 Sep 8;16:6017-6028. doi: 10.2147/IDR.S426901. eCollection 2023. Infect Drug Resist. 2023. PMID: 37705511 Free PMC article.
-
Assessment of the risk of aerosol transmission of CRKP during bronchoscopy in the intensive care unit.Antimicrob Resist Infect Control. 2025 Jul 6;14(1):81. doi: 10.1186/s13756-025-01603-9. Antimicrob Resist Infect Control. 2025. PMID: 40619408 Free PMC article.
-
Genomic Evolution of ST11 Carbapenem-Resistant Klebsiella pneumoniae from 2011 to 2020 Based on Data from the Pathosystems Resource Integration Center.Genes (Basel). 2022 Sep 10;13(9):1624. doi: 10.3390/genes13091624. Genes (Basel). 2022. PMID: 36140792 Free PMC article.
-
Genomic study substantiates the intensive care unit as a reservoir for carbapenem-resistant Klebsiella pneumoniae in a teaching hospital in China.Microb Genom. 2024 Sep;10(9):001299. doi: 10.1099/mgen.0.001299. Microb Genom. 2024. PMID: 39325028 Free PMC article.
-
Systematic review and meta-analysis on the carbapenem-resistant hypervirulent Klebsiella pneumoniae isolates.BMC Pharmacol Toxicol. 2025 Jan 30;26(1):25. doi: 10.1186/s40360-025-00857-8. BMC Pharmacol Toxicol. 2025. PMID: 39885589 Free PMC article.
References
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources